Creative Financial Designs’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4K Hold
266
– – ﹤0.01% 1226
2026
Q1
$23K Buy
266
+1
+0.4% +$88 ﹤0.01% 1162
2025
Q4
$22.5K Buy
265
+2
+0.8% +$160 ﹤0.01% 1119
2025
Q3
$19.1K Buy
263
+1
+0.4% +$69 ﹤0.01% 1160
2025
Q2
$17.2K Buy
262
+1
+0.4% +$65 ﹤0.01% 1181
2025
Q1
$18.4K Buy
261
+2
+0.8% +$139 ﹤0.01% 1111
2024
Q4
$17.1K Hold
259
– – ﹤0.01% 1087
2024
Q3
$18.3K Buy
259
+2
+0.8% +$139 ﹤0.01% 1056
2024
Q2
$17.1K Buy
257
+1
+0.4% +$66 ﹤0.01% 1034
2024
Q1
$17.4K Buy
256
+1
+0.4% +$66 ﹤0.01% 1007
2023
Q4
$15.8K Buy
+255
New +$15K ﹤0.01% 977
2017
Q4
– Sell
-120
Closed -$6K – 734
2017
Q3
$6K Hold
120
– – ﹤0.01% 478
2017
Q2
$6K Sell
120
-405
-77% -$20.5K ﹤0.01% 489
2017
Q1
$26K Sell
525
-1,740
-77% -$86.1K 0.02% 292
2016
Q4
$107K Buy
+2,265
New +$107K 0.09% 170

Other funds holding IHE

Creative Financial Designs's IHE Position: Q2 2026 in Review

Creative Financial Designs held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 266 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Creative Financial Designs first reported a position in IHE in Q4 2016 and has held it in 15 quarters since. The position peaked at $107K in Q4 2016. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Creative Financial Designs held 266 shares of iShares US Pharmaceuticals ETF worth $26.4K as of Q2 2026.
  • Creative Financial Designs left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1226 holding.
  • Creative Financial Designs first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and has held it in 15 quarters since.
  • Creative Financial Designs's iShares US Pharmaceuticals ETF position peaked at $107K in Q4 2016.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.